Using Transcutaneous Auricular Vagus Nerve Stimulation to Treat Acute Alcohol Withdrawal
Key facts
- Who runs it
- Northwell Health
- Where
- Manhasset, United StatesSee the site
- Trial code
- Status
- Withdrawn
- Started
- 31 Jan 2024
- Ended
- 30 Jan 2025
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Transcutaneous Nerve Stimulation
- Sham Stimulation
- Record updated
- 13 March 2024
- Why it stopped
- Study site, detoxification unit at South Oaks Hospital, was closed/partially open. Northwell addiction has been unable to provide any projected/workable plan(s).
Who can take part
- Age
- 18 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (13)Hide the full registry criteria
Who can take part
- age 18-65 years (men and women)
- primary current diagnosis of DSM-V Alcohol Use Disorder as indicated at admission
- being admitted to inpatient detoxification unit
- no evidence of significant cognitive impairment with a mini mental state examination (MMSE; Folstein et al., 1975) score > 22
- able and willing to give written informed consent and comply with the requirements of the study protocol
Who cannot take part
- treatment with an anti-cholinergic medication, including over the counter medications,
- implantable electronic devices such as pacemakers, defibrillators, hearing aids, cochlear implants or deep brain stimulators
- current DSM-V substance use disorders (other than tobacco / cannabis/ alcohol)
- serious psychiatric illnesses, e.g. psychotic disorders or bipolar disorder
- severe medical illnesses, present or history of, e.g. hepatic encephalopathy, delirium
- history of significant medical problems associated with drinking including seizures
- severe intellectual/cognitive deficits due to Korsakoff's syndrome, dementia, head injury, or others
- pregnancy
Where in United States
- Feinstein Institutes for Medical Research - Northwell HealthManhasset, United States
About the trial
What the trial wants to find out
The purpose of this study is to see if stimulation of the vagus nerve via a non-invasive device placed behind external ear can reduce physical and psychological discomfort during acute alcohol withdrawal in patients with alcohol use disorder when people just stop drinking alcohol and in detoxification stage.
The 2 groups in the trial
- VNS transcutaneous stimulationTreatment being tested
5 minutes of stimulation (VNS) twice a day for 4 days. Patients will receive transcutaneous stimulation (30 Hz, 300 msec.) on the auricular branch of the vagus nerve 5 minutes twice a day for 4 days. Due to the theoretical risk that right vagus nerve stimulation could affect the heart, and to ensure consistency of the intervention, all subjects randomized to receive transcutaneous vagus nerve stimulation will receive stimulation of the auricular branch of the left vagus nerve. The subject will be blinded to their treatment arm. The device to be used will include a handheld electrical pulse generator and a pair of electrodes to be placed at the ear for stimulation. The specific target at the ear will be the auricular branch of the vagus nerve, which innervates the skin of a specific ear area termed "Cymba Concha". Electrodes will be placed on this area to provide stimulation to the auricular branch of the afferent vagus nerve.
Treatment: Transcutaneous Nerve Stimulation
- Sham stimulationSham treatment, for comparison
5 minutes of sham stimulation (no electrical stimulation) twice a day for 4 days Patients will receive sham stimulation on the auricular branch of the vagus nerve 5 minutes twice a day for 4 days. The subject will be blinded to their treatment arm. The specific target at the ear will be the auricular branch of the vagus nerve, which innervates the skin of a specific ear area termed "Cymba Concha". Electrodes will be placed on this area to provide sham stimulation (no electrical current) to the auricular branch of the afferent vagus nerve.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 13 March 2024